Merck buzzes Dragonfly for 2nd immunotherapy candidate in $700M pact
Updated: Aug 30, 2022

The dragon is flying high today as Merck hits go on a second immunotherapy candidate from its $700 million pact with Dragonfly Therapeutics. The Big Pharma's buy-in comes just a month after Bristol Myers Squibb licensed its sixth drug from the biotech.
Merck teamed up with Dragonfly for $695 million per program in an October 2018 pact targeting multiple solid tumors. The New Jersey pharma opted into the first TriNKET candidate last November, and the two expanded the collaboration to include infectious diseases and immune disorders on top of the original oncology tie-up.
The partnership revolves around the Massachusetts biotech's TriNKET, or Tri-specific, natural killer (NK) cell engager therapeutics. Essentially, the tech binds to surface proteins expressed on cancer and NK cells.
In disclosing the news Tuesday, Dragonfly's CEO Bill Haney copied and pasted his statement about the collaboration from last year's initial opt-in, noting Merck is a "powerful world leader in drug development" and the biotech is "delighted" the pharma wants to continue with them.
BMS is also happy to keep its partnership with the biotech alive. The Big Pharma signed up for its sixth drug in its own collaboration with Dragonfly last month.
That partnership, originally inked in 2017, has evolved to include hematology malignancies, oncology and neuroinflammation. The TriNKET immunotherapy platform comprises five of the six licensed drugs with the New York Big Pharma.



Mình có lần lướt đọc mấy trao đổi trên mạng شيخ روحاني thì thấy nhắc nên cũng tò mò mở ra xem thử cho biết. Mình không tìm hiểu sâu جلب الحبيب chỉ xem qua trong thời gian ngắn để quan sát bố cục جلب الحبيب cách sắp xếp شيخ روحاني các mục và trình bày nội شيخ روحاني dung tổng thể. Cảm giác là các phần được trình bày khá gọn, các Berlinintim mục rõ ràng nên đọc lướt cũng không bị rối جلب الحبيب với mình như Berlinintim vậy là đủ để nắm tin cơ bản rồi. جلب الحبيب
,
,
Thank you for sharing such an informative blog. The information will certainly help many students planning to study abroad. It's always great to see high-quality educational content online. WTS Study Abroad Consultants also focuses on helping students find the right university and build a successful international education journey.
The part about Merck visiting Dragonfly and taking the time to learn more about the work being done there stood out because it shows how meaningful those industry connections can be beyond a single meeting. It’s interesting how conversations like these often create opportunities for sharing ideas and understanding different approaches, even when the long-term outcomes aren’t immediately visible. It also reminded me that people value clear explanations in many different settings, whether they’re reading about collaborations like this or looking for Engineering Assignment Help Online to better understand technical concepts. I’m curious whether that visit led to any lasting projects or partnerships, since those follow-up stories are often just as interesting as the original announcement.
This was a very engaging and insightful post that provided valuable guidance for students facing academic challenges. I really liked how the author explained everything in a simple and practical way, making the content easy to understand. As a university student, I often read blogs like this to improve my study skills and stay motivated. During demanding semesters, many learners search for Assignment Help in UK as well as Dissertation Writing Help to better manage their coursework and research projects. Posts like this encourage continuous learning and help students approach their academic goals with greater confidence.
The partnership between Merck and Dragonfly highlights how major pharmaceutical companies continue investing in innovative immunotherapy research to expand future treatment possibilities. A $700 million agreement reflects confidence in promising early-stage science, while also recognizing the risks involved in drug development. Collaborations like this can accelerate discoveries by combining expertise, funding, and advanced research capabilities. It will be interesting to see how this candidate progresses through clinical trials and whether it delivers meaningful benefits for patients. On another note, USA Embroidery Digitizing demonstrates how specialized industries also thrive through precision, innovation, and collaborative expertise. Across different fields, innovation drives progress.